Cargando…
The COPD Foundation's COPD360Net Initiative Approach to Patient-Centric Drug Development: A Case Study in Using Patient Surveys to Inform New Treatments for Viral Respiratory Infections
Patient-centric drug development is crucial to creating treatments that address unmet patient needs but is often ignored. The COPD Foundation's COPD360Net(®) 1. Of the 376 respondents with COPD surveyed, frequent exacerbators reported strong interest in a new type of antiviral nasal spray to pr...
Autores principales: | Tal-Singer, Ruth, Miller, Bruce E, Rommes, Jean M, Luttmann, Mark A, Demaison, Christophe, Bradley Drummond, M, Pasquale, Cara B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893385/ https://www.ncbi.nlm.nih.gov/pubmed/36741822 http://dx.doi.org/10.1177/23743735231151554 |
Ejemplares similares
-
COVID-19 CHANGING RECOMMENDATIONS AND INFORMATION: THE IMPACT ON THE COPD COMMUNITY
por: PASQUALE, CARA, et al.
Publicado: (2021) -
COPD association and repeatability of blood biomarkers in the ECLIPSE cohort
por: Dickens, Jennifer A, et al.
Publicado: (2011) -
Effect of inhaled corticosteroids on blood eosinophil count in steroid-naïve patients with COPD
por: Kreindler, James L, et al.
Publicado: (2016) -
Multiple biomarkers predict disease severity, progression and mortality in COPD
por: Zemans, Rachel L., et al.
Publicado: (2017) -
Sputum neutrophils as a biomarker in COPD: findings from the ECLIPSE study
por: Singh, Dave, et al.
Publicado: (2010)